Erratum: Evaluating the cost-effectiveness of prenatal surgery for myelomeningocele: A decision analysis (Ultrasound in Obstetrics and Gynecology (2012) 40 (58-164) DOI: 10.1002/uog.11176);Evaluating the cost-effectiveness of prenatal surgery for myelomeningocele: A decision analysis

Ultrasound in Obstetrics and Gynecology

Volumn 40, Issue 2, 2012, Pages 158-164

  Werner, E F ^a   Han, C S ^b   Burd, I ^a   Lipkind, H S ^b   Copel, J A ^b   Bahtiyar, M O ^b   Thung, S F ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

cost effectiveness; in utero surgery; myelomeningocele; prenatal surgery or repair; spina bifida

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MENINGOMYELOCELE; NEWBORN; OBSTETRIC OPERATION; PREGNANCY; STATISTICS; TIME;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT, NEWBORN; MENINGOMYELOCELE; OBSTETRIC SURGICAL PROCEDURES; PREGNANCY; TIME FACTORS;

EID: 84864774850     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.12522     Document Type: Erratum

References (30)

1. Canfield MA, Collins JS, Botto LD, Williams LJ, Mai CT, Kirby RS, Pearson K, Devine O, Mulinare J,; National Birth Defects Prevention Network. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 2005; 73: 679-689. (Pubitemid 41572010)
2. Norem CT, Schoen EJ, Walton DL, Krieger RC, O'Keefe J, To TT, Ray T,. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol 2005; 106: 747-752. (Pubitemid 41362178)
3. Talamonti G, D'Aliberti G, Collice M,. Myelomeningocele: long-term neurosurgical treatment and follow-up in 202 patients. J Neurosurg 2007; 107 (5 Suppl): 368-386.
4. Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta M, Tulipan NB, D'Alton ME, Farmer DL,; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364: 993-1004.
5. Wilson RD, Lemerand K, Johnson MP, Flake AW, Bebbington M, Hedrick HL, Adzick NS,. Reproductive outcomes in subsequent pregnancies after a pregnancy complicated by open maternal-fetal surgery (1996-2007). Am J Obstet Gynecol 2010; 203: 209.e1-6.
6. Ouyang L, Grosse SD, Armour BS, Waitzman NJ,. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol 2007; 79: 552-558. (Pubitemid 47068191)
7. Bamer AM, Connell FA, Dudgeon BJ, Johnson KL,. Frequency of purchase and associated costs of assistive technology for Washington State Medicaid program enrollees with spina bifida by age. Disabil Health J 2010; 3: 155-161.
8. Harris MB, Banta JV,. Cost of skin care in the myelomeningocele population. J Pediatr Orthop 1990; 10: 355-361. (Pubitemid 20250910)
9. Russell RB, Green NS, Steiner CA, Meikle S, Howse JL, Poschman K, Dias T, Potetz L, Davidoff MJ, Damus K, Petrini JR,. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 2007; 120: e.1-9. (Pubitemid 47036210)
10. Patwardhan RV, Nanda A,. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005; 56: 139-144; discussion 144-145. (Pubitemid 40053997)
11. Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI,. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010; 66: 284-289.
12. Limonadi FM, Selden NR,. Dura-splitting decompression of the craniocervical junction: reduced operative time, hospital stay, and cost with equivalent early outcome. J Neurosurg 2004; 101 (2 Suppl): 184-188. (Pubitemid 39426192)
13. Mehta VA, Bettegowda C, Ahmadi SA, Berenberg P, Thomale UW, Haberl EJ, Jallo GI, Ahn ES,. Spinal cord tethering following myelomeningocele repair. J Neurosurg Pediatr 2010; 6: 498-505.
14. Nicholson WK, Frick KD, Powe NR,. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol 2000; 96: 95-101. (Pubitemid 30336288)
15. Landon MB, Spong CY, Thom E, Hauth JC, Bloom SL, Varner MW, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O'sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG,; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol 2006; 108: 12-20. (Pubitemid 44336839)
16. Tilford JM, Grosse SD, Robbins JM, Pyne JM, Cleves MA, Hobbs CA,. Health state preference scores of children with spina bifida and their caregivers. Qual Life Res 2005; 14: 1087-1098. (Pubitemid 40685231)
17. Oakeshott P, Hunt GM, Poulton A, Reid F,. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol 2010; 52: 749-753.
18. Arias E,. United States life tables, 2003. Natl Vital Stat Rep 2006; 54: 1-40.
19. Chung A, Macario A, El-Sayed Y, Riley ET, Duncan B, Druzin ML,. Cost-effectiveness of a trial of labor after previous cesarean. Obstet Gynecol 2001; 97: 932-941. (Pubitemid 32522491)
20. Caughey AB, Sandberg PL, Zlatnik MG, Thiet MP, Parer JT, Laros RK,. Forceps compared with vacuum: rates of neonatal and maternal morbidity. Obstet Gynecol 2005; 106: 908-912. (Pubitemid 41532893)
21. Moster D, Lie RT, Markestad T,. Long-term medical and social consequences of preterm birth. N Engl J Med 2008; 359: 262-273. (Pubitemid 352008441)
22. Teng TO, Wallace A,. One thousand health-related quality-of-life estimates. Med Care 2000; 38: 583-637.
23. Golombeck K, Ball RH, Lee H, Farrell JA, Farmer DL, Jacobs VR, Rosen MA, Filly RA, Harrison MR,. Maternal morbidity after maternal-fetal surgery. Am J Obstet Gynecol 2006; 194: 834-839. (Pubitemid 43333162)
24. Sin AH, Rashidi M, Caldito G, Nanda A,. Surgical treatment of myelomeningocele: year 2000 hospitalization, outcome, and cost analysis in the US. Childs Nerv Syst 2007; 23: 1125-1127. (Pubitemid 47399544)
25. Tan JM, Macario A, Carvalho B, Druzin ML, El-Sayed YY,. Cost-effectiveness of external cephalic version for term breech presentation. BMC Pregnancy Childbirth 2010; 10: 3.
26. Kaufman KE, Bailit JL, Grobman W,. Elective induction: an analysis of economic and health consequences. Am J Obstet Gynecol 2002; 187: 858-863. (Pubitemid 35178370)
27. Halpern NA, Pastores SM,. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med 2010; 38: 65-71.
28. Kuy S, Roman SA, Desai R, Sosa JA,. Outcomes following cholecystectomy in pregnant and nonpregnant women. Surgery 2009; 146: 358-366.
29. Kirkby S, Greenspan JS, Kornhauser M, Schneiderman R,. Clinical outcomes and cost of the moderately preterm infant. Adv Neonatal Care 2007; 7: 80-87.
30. Verbeek RJ, Heep A, Maurits NM, Cremer R, Hoving EW, Brouwer OF, van der Hoeven JH, Sival DA,. Fetal endoscopic myelomeningocele closure preserves segmental neurological function. Dev Med Child Neurol 2012; 54: 15-22.